Literature DB >> 15800234

Immunosuppressive drugs and the risk of cancer after organ transplantation.

Jacques Dantal, Jean-Paul Soulillou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15800234     DOI： 10.1056/NEJMe058018

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  51 in total

1.  New issues in heart transplantation for heart failure.

Authors:  Michelle M Kittleson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  Humanizing animal models: a key to autoimmune diabetes treatment.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Sci Transl Med       Date:  2011-02-02       Impact factor: 17.956

3.  How can we improve the translational landscape for a faster cure of type 1 diabetes?

Authors:  Matthias von Herrath; Andrew Chan
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

Review 4.  Will regenerative medicine replace transplantation?

Authors:  Giuseppe Orlando; Shay Soker; Robert J Stratta; Anthony Atala
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

5.  Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Authors:  Jordi Rovira; María José Ramírez-Bajo; Elisenda Banon-Maneus; Marta Lazo-Rodríguez; Daniel Moya-Rull; Natalia Hierro-Garcia; Valeria Tubita; Gastón J Piñeiro; Ignacio Revuelta; Pedro Ventura-Aguiar; David Cucchiari; Federico Oppenheimer; Mercè Brunet; Josep M Campistol; Fritz Diekmann
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

6.  Calcineurin ensures a link between the DNA replication checkpoint and microtubule-dependent polarized growth.

Authors:  Kazunori Kume; Takayuki Koyano; Muneyoshi Kanai; Takashi Toda; Dai Hirata
Journal:  Nat Cell Biol       Date:  2011-02-20       Impact factor: 28.824

7.  Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.

Authors:  Dipak Datta; Alan G Contreras; Aninda Basu; Olivier Dormond; Evelyn Flynn; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

8.  Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.

Authors:  Ping Yu; Sidong Xiong; Qiuzao He; Yiwei Chu; Chi Lu; Charmaine A Ramlogan; Jason C Steel
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

9.  Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 17.152

10.  Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Authors:  Kwan-Hyuck Baek; Alexander Zaslavsky; Ryan C Lynch; Carmella Britt; Yoshiaki Okada; Richard J Siarey; M William Lensch; In-Hyun Park; Sam S Yoon; Takashi Minami; Julie R Korenberg; Judah Folkman; George Q Daley; William C Aird; Zygmunt Galdzicki; Sandra Ryeom
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.